1 |
Anita, E. Y., A. N. Murphy, and W. G. Stetler-Stevenson (1998), 72 kDa gelatinase (gelatinase A) : structure, activation, regulation, and substrate specificity, In Matrix Metalloproteinase, W. C. Parks and R. F. Mecham, Eds., pp. 85-113, Academic Press. London. UK
|
2 |
Nagase, H. (1997), Activation mechanisms of matrix metalloproteinases, J. Biol. Chem. 378, 151-160
|
3 |
Lee, H. J., H. J. Lee, E. S. Lim, K. S. Ahn, B. S. Shim, H. M. Kim, S. J. Gong, D. K. Kim, and S. H. Kim (2005), Cambodian Phellinus linteus inhibits experimental metastasis of melanoma cells in mice via regulation of urokinase type plasminogen activator, Biol. Pharmaceu. Bull. 28, 27-31
DOI
ScienceOn
|
4 |
Baird, A. (1994), Fibroblast growth factors: activities and significance of non-neurotrophin neurotrophic growth factors, Curr. Opin. Neurobiol. 4, 78-86
DOI
ScienceOn
|
5 |
Kinoshita, M. and K. Shimokado (1999), Autocrine FGF-2 is responsible for the cell density-dependent susceptibility to apoptosis of HUVEC : A role of a calpain inhibitor-sensitive mechanism, Arterioscler. Thromb. Vasc. Biol. 19, 2323-2329
DOI
ScienceOn
|
6 |
Chae, J. K., L. Kim, S. T, Lim, M. J. Chung, W. H. Kim, H. G. Kim, and G. Y. Koh (2000), Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization, Arterioscler. Thromb. Vasc. Biol. 20, 2573-2578
DOI
ScienceOn
|
7 |
Ferrara, N. and K. Alitalo (1999), Clinical applications of angiogenic growth factors and their inhibitors, Nat. Med. 5, 1359-1364
DOI
ScienceOn
|
8 |
Klagsbrun, M. and P. A. D'Amore (1991), Regulators of angiogenesis, Annu. Rev. physiol. 53, 217-239
DOI
ScienceOn
|
9 |
Nguyen, Q., F. Willenbrock, M. I. Cockett, M. O'Shea, A. J. Docherty, and G. Murphy (1994), Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A, Biochemistry 33, 2089-2095
DOI
ScienceOn
|
10 |
Millauer, B., S. Wizigmann-Voos, H. Schnurch, R. Martinez, N. P. Moller, W. Risau, and A. Ullrich (1993), High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis, Cell 72, 835-846
DOI
ScienceOn
|
11 |
Kim, I., S. O. Moon, K. N. Koh, H. Kim, C. S. Uhm, H. J. Kwak, N. G. Kim, and G. Y. Koh (1999), Molecular cloning, expression, and characterization of angiopoietin-related protein induces endothelial cell sprouting, J. Biol. Chem. 274, 26523-26528
DOI
|
12 |
Kim, H. G. and G. Y. Koh (2000), Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kB-dependent pathway, Biochem. Biophys. Res. Commu. 269, 401-405
DOI
ScienceOn
|
13 |
Oh, I. S., J. W. Han, and H. G. Kim (2005), Water extracts of Aralia elata root bark enhances migration and matrix metalloproteinases secretion in porcine coronary artery endothelial cells, Biotechnol. Bioprocess Eng. 10, 372-377
과학기술학회마을
DOI
ScienceOn
|
14 |
Okumura, Y., H. Sato, M. Seiki, and H. Kido (1997), Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator, FEBS. Lett. 402, 181-184
DOI
|
15 |
Risau, W. (1997), Mechanisms of angiogenesis, Nature 386, 671-674
DOI
ScienceOn
|
16 |
Zhou, Z., S. S. Apte, R. Soininen, R. Cao, G. Y. Baaklini, R. W. Rauser, J. Wang, Y. Cao, and K. Tryggvason (2000), Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I, Proc. Natl. Acad. Sci. 97, 4052-4057
|
17 |
Benbow, U., G. Buttice, H. Nagase, and M. Kurkinen (1996), Characterization of the 46-kDa intermediates of matrix metalloproteinase 3 (stromelysin 1) obtained by site-directed mutation of phenylalanine 83, J. Biol. Chem. 271, 10715-10722
DOI
|
18 |
Davis, G. E. and D. R. Senger (2005), Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization, Circ. Res. 97, 1093-1107
DOI
ScienceOn
|
19 |
Coussens, L. M. and Z. Werb (1996), Matrix metalloproteinases and the development of cancer, Chem. Biol. 3, 895-904
DOI
ScienceOn
|
20 |
Pepper, M. S. (2001), Extracellular proteolysis and angiogenesis, Thromb. Haemost. 86, 346-355
DOI
|
21 |
Sounni, N. E. and A. Noel (2005), Membrane type-matrix metalloproteinases and tumor progression, Biochimie 87, 329-342
DOI
ScienceOn
|
22 |
Nelson, A. R., B. Fingleton, M. L. Rothenberg, and L. M. Matrisian (2000), Matrix metalloproteinases: biologic activity and clinical implications, J. Clin. Oncol. 18, 1135-1149
DOI
|
23 |
Shon, Y. H. and K. S. Nam (2001), Antimutagenicity and induction of anticancinogenic phase II enzymes by basidiomycetes, J. Ethnopharmacol. 77, 103-109
DOI
ScienceOn
|
24 |
Kim, H. M., S. B. Han, G. T. Oh, Y. H. Kim, D. H. Hong, N. D. Hong, and I. D. Yoo (1996), Stimulation of humoral and cell mediated immunity by polysaccharide from mushroom Phellinus linteus, International J. Immunopharmacol. 18, 295-303
DOI
ScienceOn
|
25 |
Folkman, J. and Y. Shing (1992), Angiogenesis, J. Biol. Chem. 267, 10931-10934
|
26 |
Grant, D. S. and H. K. Kleinman (1997), Regulation of capillary formation by laminin and other components of the extracellular matrix, EXS 79, 317-333
|
27 |
Frederick, J. and J. F. Woessner Jr. (1998), The matrix metallo-proteinase family, In Matrix Metalloproteinase, W. C. Parks and R. F. Mecham, Eds., pp. 1-14, Academic Press. London. UK
|
28 |
Song, Y. S., S. H. Kim, J. H. Sa, C. Jin, C. J. Lim, and E. H. Park (2003), Anti-angiogenic, antioxidant and xanthine oxidase inhibition activities of the mushroom Phellinus linteus, J. Ethnopharmacol. 88, 113-116
DOI
ScienceOn
|